195 related articles for article (PubMed ID: 32968454)
1. High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis.
Cai H; Shao B; Zhou Y; Chen Z
Oncol Lett; 2020 Nov; 20(5):232. PubMed ID: 32968454
[TBL] [Abstract][Full Text] [Related]
2. High expression of
Cai H; Zhu X; Qian F; Shao B; Zhou Y; Zhang Y; Chen Z
Transl Cancer Res; 2020 Feb; 9(2):983-992. PubMed ID: 35117443
[TBL] [Abstract][Full Text] [Related]
3. Noval ceRNA axis-mediated high expression of
Wang XQ; Li LL; Lou P; Zhang Q; Wang Y
Transl Cancer Res; 2023 Dec; 12(12):3486-3502. PubMed ID: 38193002
[TBL] [Abstract][Full Text] [Related]
4. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
[TBL] [Abstract][Full Text] [Related]
5. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between TOPA2A gene expression and the number of CD4
Lu X; Yu P; Tao H; Chen Y; Lu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jan; 38(1):24-31. PubMed ID: 35078572
[TBL] [Abstract][Full Text] [Related]
7. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
Meng J; Wei Y; Deng Q; Li L; Li X
Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.
Ong KH; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Chan TC; Li CF; Kuo YH
Front Biosci (Landmark Ed); 2023 Apr; 28(4):75. PubMed ID: 37114547
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
10. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
11. Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma.
Feng J; Wei X; Liu Y; Zhang Y; Li G; Xu Y; Zhou P; Zhang J; Han X; Zhang C; Zhang Y; Wang G
Aging (Albany NY); 2023 Nov; 15(22):13010-13040. PubMed ID: 37980167
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
13. TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p.
Wang T; Lu J; Wang R; Cao W; Xu J
J Cancer; 2022; 13(2):589-601. PubMed ID: 35069905
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
[TBL] [Abstract][Full Text] [Related]
15. A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Tian D; Yu Y; Zhang L; Sun J; Jiang W
Front Med (Lausanne); 2021; 8():681388. PubMed ID: 34568357
[No Abstract] [Full Text] [Related]
16.
Zhao H; Chen C; Song H; Qin R; Wang X; He Q; Li F; Zhao H; Li Y
Oxid Med Cell Longev; 2022; 2022():4277254. PubMed ID: 36299605
[No Abstract] [Full Text] [Related]
17. TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.
Wang Z; Zhu Q; Li X; Ren X; Li J; Zhang Y; Zeng S; Xu L; Dong X; Zhai B
Am J Cancer Res; 2022; 12(9):4343-4360. PubMed ID: 36225636
[TBL] [Abstract][Full Text] [Related]
18. ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis.
Song R; Huang J; Yang C; Li Y; Zhan G; Xiang B
Int J Gen Med; 2022; 15():8381-8398. PubMed ID: 36465268
[TBL] [Abstract][Full Text] [Related]
19. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
20. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
